CSR Policy

Introduction

At Inborn, we are dedicated to responsible innovation in biomedical materials for the treatment of bone diseases. Our research and development in bone-mimicking hydroxyapatite and gelatin-based colloidal gels aim to improve patient outcomes while maintaining ethical, sustainable, and socially responsible practices.

This CSR policy aligns with the OECD Guidelines for Multinational Enterprises, ensuring human rights protection, environmental sustainability, fair labor practices, and ethical business conduct throughout our operations.

Ethical Business Conduct

We uphold the highest ethical standards in our business, research, and development activities.

Legal Compliance: We adhere to all applicable laws, regulations, and industry standards, including ISO 13485, MDR (EU 2017/745), and FDA guidelines.

Anti-Corruption & Bribery: We maintain a zero-tolerance policy for bribery, fraud, extortion, and any unethical business practices.

Fair Competition: We engage in fair and transparent business practices, avoiding unfair competitive advantages, insider trading, and conflicts of interest.

Confidentiality & Data Protection: We protect intellectual property, trade secrets, and patient data in compliance with GDPR and relevant privacy laws.

Human Rights & Labor Practices

Inborn upholds international human rights principles and ensures fair labor practices across all operations.

Diversity & Inclusion: We foster a diverse and inclusive workplace, ensuring equal opportunities regardless of race, gender, nationality, disability, or sexual orientation.

Fair Wages & Working Conditions: We provide fair wages, safe working environments, and respect employees’ rights to collective bargaining.

No Child or Forced Labor: We strictly prohibit child labor, forced labor, or any form of human trafficking in our operations and supply chain.

Environmental Responsibility

As a biomedical materials company, we recognize the impact of material sourcing, manufacturing, and disposal on the environment and promoting sustainability.

Sustainable Sourcing: We prioritize biodegradable materials and sustainable sourcing of hydroxyapatite and gelatin nanoparticles.

Eco-Friendly Production: We implement green manufacturing processes to minimize waste, reduce carbon footprint, and ensure responsible use of chemicals.

Regenerative Biomedical Research: Our goal is to develop biodegradable, non-toxic, and sustainable medical solutions that support bone regeneration while reducing reliance on synthetic implants.

Research & Innovation Ethics

Inborn is committed to scientific integrity and ethical biomedical innovation.

Responsible Research: All research follows ethical guidelines for clinical trials, including ISO 10993-6 for biocompatibility.

Animal & Human Testing: We minimize the use of animal testing and ensure ethical, legally approved procedures.

Scientific Transparency: We promote open science, peer-reviewed research, and data integrity.

Patient Safety & Quality: All products undergo rigorous testing and regulatory reviews before clinical applications.

Open Science & Collaboration: We engage in scientific transparency, publishing findings that contribute to medical progress.

Responsible Supply Chain & Partnerships

We require all suppliers, manufacturers, and business partners to adhere to our CSR and sustainability principles.

Supplier Code of Conduct: Our suppliers must comply with labor laws, human rights standards, and environmental regulations.

No Exploitation: We do not engage with suppliers involved in unethical practices, forced labor, or environmental harm.

Ethical Sourcing: We prioritize partners committed to sustainability, fair trade, and responsible raw material procurement.

Community Engagement & Social Impact

Inborn believe in giving back to society through education, healthcare support, and community engagement.

STEM Education Support: We invest in STEM education programs to inspire young scientists in biomedical engineering.

Affordable Healthcare Advocacy: We support initiatives promoting access to advanced medical treatments.

Partnerships with Hospitals & Researchers: We collaborate with orthopedic surgeons, universities, and research institutions to drive medical innovation.

Governance and Responsibility

Our sustainability efforts are overseen by the Board of Directors, which holds ultimate responsibility for the company’s operations. The Board has established policies and guidelines related to environmental aspects, as well as a Code of Conduct that applies to all employees, encompassing anti-bribery, anti-corruption, and human rights practices.

To ensure effective implementation of the Board’s decisions, the CEO is responsible for driving progress, with the Executive Vice President of Quality Management & Regulatory Affairs leading the group’s sustainability work within the management team. Additionally, a dedicated sustainability working group has been established within the company to further support and advance our sustainability initiatives.

Anti-Corruption & Compliance with International Laws

Inborn is committed to legal compliance and has the highest standards of corporate governance.

Zero-Tolerance Policy on Corruption: We strictly prohibit bribery, fraud, and unethical lobbying.

GDPR & Data Protection Compliance: We ensure secure handling of patient and research data.

Regular CSR Audits & Reporting: We conduct annual CSR evaluations, including environmental impact assessments.

Reporting Violations & Whistleblower Protection

Inborn encourages a speak-up culture and ensures no retaliation against employees or partners who report ethical concerns.

Anonymous Reporting Channels: Employees can report violations of this policy confidentially.

Whistleblower Protection: No one will face retaliation for reporting ethical breaches in good faith.

CSR Implementation & Reporting

We actively monitor and improve our CSR performance through:

Annual CSR Self-Scan: Completing the Dutch CSR self-scan for international business compliance.

Internal CSR Training: Educating employees about CSR principles, ethics, and sustainability.

Public CSR Reports: Publishing an annual CSR report detailing our progress, challenges, and future goals.

Commitment to Continuous Improvement

We are committed to enhancing our CSR efforts and invite feedback from employees, partners, stakeholders, and regulatory bodies. Inborn will continue to innovate responsibly, ensuring that our products and practices benefit patients, healthcare systems, and the global environment.

Sustainable Development Goals

Sustainable Development Goals (SDGs) aim at eradicating poverty, halting climate change and creating peaceful and safe societies. Inborn has identified below SDGs as being the most essential to business and where Inborn has the greatest opportunity to influence. The sustainability working group continues to work to set targets for future improvements within these SDGs.